Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-03 Purchase | 2026-08-12 9:43 pm | Hepion Pharmaceuticals Inc. | HEPA | Stetz Gary S. II Director | 500,000 | $0.05 | $25,000 | 1,000,000 (Direct) | View |
| 2026-08-03 Purchase | 2026-08-12 9:41 pm | Hepion Pharmaceuticals Inc. | HEPA | Stetz Gary S. Interim CEO | 2,000,000 | $0.05 | $100,000 | 5,250,000 (Direct) | View |
| 2026-08-03 Purchase | 2026-08-12 9:39 pm | Hepion Pharmaceuticals Inc. | HEPA | Purcell Michael J. Director | 2,000,000 | $0.05 | $100,000 | 5,250,000 (Direct) | View |
| 2026-08-03 Purchase | 2026-08-12 9:36 pm | Hepion Pharmaceuticals Inc. | HEPA | Appajosyula Sireesh Chief Operating Officer | 2,000,000 | $0.05 | $100,000 | 5,250,000 (Direct) | View |
| 2026-08-03 Purchase | 2026-08-12 9:34 pm | Hepion Pharmaceuticals Inc. | HEPA | LoPriore Vincent S Executive Chairman | 10,000,000 | $0.05 | $500,000 | 34,250,000 (Indirect) | View |
| 2026-04-21 Purchase | 2026-04-27 5:33 pm | Hepion Pharmaceuticals Inc. | HEPA | Purcell Michael J. Director | 1,250,000 | $0.04 | $50,000 | 1,250,000 (Direct) | View |
| 2026-04-21 Purchase | 2026-04-27 06:24 am | Hepion Pharmaceuticals Inc. | HEPA | LoPriore Vincent S Executive Chairman 10% Owner | 6,250,000 | $0.04 | $250,000 | 6,250,000 (Indirect) | View |
| 2026-04-21 Purchase | 2026-04-27 06:24 am | Hepion Pharmaceuticals Inc. | HEPA | Appajosyula Sireesh Director | 1,250,000 | $0.04 | $50,000 | 1,250,000 (Direct) | View |
| 2026-04-21 Purchase | 2026-04-27 06:24 am | Hepion Pharmaceuticals Inc. | HEPA | Stetz Gary S. Interim CEO | 1,250,000 | $0.04 | $50,000 | 1,250,000 (Indirect) | View |
| 2023-11-24 Purchase | 2023-11-28 06:55 am | Hepion Pharmaceuticals Inc. | HEPA | Wijngaard Peter Director | 5,000 | $3.07 | $15,350 | 9,501 (Direct) | View |
| 2023-09-15 Purchase | 2023-09-20 11:27 am | Hepion Pharmaceuticals Inc. | HEPA | Wijngaard Peter Director | 3,000 | $5.6137 | $16,841 | 4,501 (Direct) | View |
| 2023-09-18 Purchase | 2023-09-19 09:01 am | Hepion Pharmaceuticals Inc. | HEPA | Foster Robert T CEO and Director | 1,600 | $5.6 | $8,960 | 50,470 (Direct) | View |
| 2023-09-15 Purchase | 2023-09-18 08:00 am | Hepion Pharmaceuticals Inc. | HEPA | Foster Robert T CEO,CSO and Director | 1,600 | $5.4 | $8,640 | 48,870 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-19 Option Award | 2026-08-21 4:36 pm | 2026-08-19 2036-08-19 | Hepion Pharmaceuticals Inc. | HEPA | Stetz Gary S. Interim CEO | 1,345,500 | $0 | 1,345,500 (Direct) | View |
| 2026-08-19 Option Award | 2026-08-21 4:34 pm | 2026-08-19 2036-08-19 | Hepion Pharmaceuticals Inc. | HEPA | LoPriore Vincent S Executive Chairman | 1,345,500 | $0 | 1,345,500 (Direct) | View |
| 2026-08-19 Option Award | 2026-08-21 4:33 pm | 2026-08-19 2036-08-19 | Hepion Pharmaceuticals Inc. | HEPA | LoPriore Chase VP, Corp. Dev. | 1,345,500 | $0 | 1,345,500 (Direct) | View |
| 2026-08-19 Option Award | 2026-08-21 4:31 pm | 2027-08-19 2036-08-19 | Hepion Pharmaceuticals Inc. | HEPA | Fisher Danina Director | 299,000 | $0 | 299,000 (Direct) | View |
| 2026-08-19 Option Award | 2026-08-21 4:30 pm | 2027-08-19 2036-08-19 | Hepion Pharmaceuticals Inc. | HEPA | Liddy James Gordon Director | 299,000 | $0 | 299,000 (Direct) | View |
| 2026-08-19 Option Award | 2026-08-21 4:29 pm | 2026-08-19 2036-08-19 | Hepion Pharmaceuticals Inc. | HEPA | Appajosyula Sireesh Chief Operating Officer | 1,345,500 | $0 | 1,345,500 (Direct) | View |
| 2026-08-19 Option Award | 2026-08-21 4:28 pm | 2027-08-19 2036-08-19 | Hepion Pharmaceuticals Inc. | HEPA | Stetz Gary S. II Director | 299,000 | $0 | 299,000 (Direct) | View |
Ownership | 2026-08-07 5:05 pm | N/A N/A | Hepion Pharmaceuticals Inc. | HEPA | Black Global 5 LLC 10% Owner | 0 | $0 | 20,000,000 (Indirect) | View |
Ownership | 2026-05-26 5:00 pm | N/A N/A | Hepion Pharmaceuticals Inc. | HEPA | LoPriore Chase Director | 0 | $0 | 1,250,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-07 4:15 pm | N/A N/A | Hepion Pharmaceuticals Inc. | HEPA | Purcell Michael J. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 8:01 pm | 2024-02-19 2034-02-19 | Hepion Pharmaceuticals Inc. | HEPA | Block Timothy M. Director | 85,000 | $0 | 99,562 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 8:01 pm | 2024-02-19 2026-02-19 | Hepion Pharmaceuticals Inc. | HEPA | JACOB GARY S Director | 85,000 | $0 | 102,120 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 8:01 pm | 2024-02-19 2034-02-19 | Hepion Pharmaceuticals Inc. | HEPA | Lbiati Kaouthar Director | 85,000 | $0 | 88,000 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 8:01 pm | 2024-02-19 2034-02-19 | Hepion Pharmaceuticals Inc. | HEPA | BRANCACCIO JOHN P Chairman | 85,000 | $0 | 99,563 (Direct) | View |
Ownership | 2022-07-20 10:34 am | N/A 2032-06-27 | Hepion Pharmaceuticals Inc. | HEPA | Lbiati Kaouthar Director | 0 | $0 | 60,000 (Direct) | View |
Ownership | 2022-07-05 08:34 am | N/A 2032-06-27 | Hepion Pharmaceuticals Inc. | HEPA | Reddi Anand Director | 0 | $0 | 60,000 (Direct) | View |